Literature DB >> 8528965

Application of ribozymes to cancer gene therapy.

M Kashani-Sabet1, K J Scanlon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8528965

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN： 0929-1903            Impact factor:   5.987


× No keyword cloud information.
  5 in total

1.  Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes.

Authors:  L M Alvarez-Salas; A E Cullinan; A Siwkowski; A Hampel; J A DiPaolo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

Review 2.  Synthetic oligonucleotides: useful molecules? A review.

Authors:  A Calogero; G A Hospers; N H Mulder
Journal:  Pharm World Sci       Date:  1997-12

3.  Tissue-specific expression of an anti-ras ribozyme inhibits proliferation of human malignant melanoma cells.

Authors:  Y Ohta; H Kijima; T Ohkawa; M Kashani-Sabet; K J Scanlon
Journal:  Nucleic Acids Res       Date:  1996-03-01       Impact factor: 16.971

4.  Generation of a ribozyme-adenoviral vector against K-ras mutant human lung cancer cells.

Authors:  Y A Zhang; J Nemunaitis; A W Tong
Journal:  Mol Biotechnol       Date:  2000-05       Impact factor: 2.695

5.  Ribozyme as an approach for growth suppression of human pancreatic cancer.

Authors:  H Kijima; K J Scanlon
Journal:  Mol Biotechnol       Date:  2000-01       Impact factor: 2.695
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.